EA199900620A1 - Фталазиноны - Google Patents

Фталазиноны

Info

Publication number
EA199900620A1
EA199900620A1 EA199900620A EA199900620A EA199900620A1 EA 199900620 A1 EA199900620 A1 EA 199900620A1 EA 199900620 A EA199900620 A EA 199900620A EA 199900620 A EA199900620 A EA 199900620A EA 199900620 A1 EA199900620 A1 EA 199900620A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
phthalasins
international
application
formula
Prior art date
Application number
EA199900620A
Other languages
English (en)
Other versions
EA002764B1 (ru
Inventor
Дер Мей Маргарета Ван
Дер Лаан Ивонне Иоханна Ван
Хендрик Тиммерман
Армин Хатцельманн
Хильдегард Босс
Дитрих Хафнер
Рольф Бойме
Ханс-Петер Клей
Original Assignee
Бык Гульден Ломберг Хемише Фабрик Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бык Гульден Ломберг Хемише Фабрик Гмбх filed Critical Бык Гульден Ломберг Хемише Фабрик Гмбх
Publication of EA199900620A1 publication Critical patent/EA199900620A1/ru
Publication of EA002764B1 publication Critical patent/EA002764B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Abstract

В заявке описаны соединения формулы Iв которых R1, R2, R3, R4 и R5 имеют значения, указанные в описании. Эти соединения являются новыми эффективными средствами для лечения заболеваний дыхательных путей.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900620A 1997-01-15 1998-01-12 Фталазиноны EA002764B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97100488 1997-01-15
PCT/EP1998/000124 WO1998031674A1 (en) 1997-01-15 1998-01-12 Phthalazinones

Publications (2)

Publication Number Publication Date
EA199900620A1 true EA199900620A1 (ru) 2000-04-24
EA002764B1 EA002764B1 (ru) 2002-08-29

Family

ID=8226366

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900620A EA002764B1 (ru) 1997-01-15 1998-01-12 Фталазиноны

Country Status (27)

Country Link
US (1) US6103718A (ru)
EP (1) EP0971901B1 (ru)
JP (1) JP2001508078A (ru)
KR (1) KR20000070150A (ru)
CN (1) CN1127487C (ru)
AT (1) ATE233247T1 (ru)
AU (1) AU735934B2 (ru)
BR (1) BR9806752A (ru)
CA (1) CA2276455C (ru)
CY (1) CY2446B1 (ru)
CZ (1) CZ293815B6 (ru)
DE (1) DE69811645T2 (ru)
DK (1) DK0971901T3 (ru)
EA (1) EA002764B1 (ru)
EE (1) EE03968B1 (ru)
ES (1) ES2193508T3 (ru)
HK (1) HK1024692A1 (ru)
HU (1) HUP0001541A3 (ru)
IL (1) IL130659A (ru)
NO (1) NO313137B1 (ru)
NZ (1) NZ336573A (ru)
PL (1) PL189418B1 (ru)
PT (1) PT971901E (ru)
SI (1) SI0971901T1 (ru)
SK (1) SK283270B6 (ru)
TR (1) TR199901653T2 (ru)
WO (1) WO1998031674A1 (ru)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3328499A (en) * 1998-03-14 1999-10-11 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone pde iii/iv inhibitors
SK287231B6 (sk) 1999-08-21 2010-04-07 Nycomed Gmbh Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
AU7654200A (en) * 1999-09-14 2001-04-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone derivatives as pd3/4 inhibitors
HUP0203487A2 (hu) 1999-10-25 2003-02-28 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahidrotiopirán-ftalazinon-származékok, mint PDE4-inhibitorok és ezeket tartalmazó gyógyszerkészítmények
AU781503B2 (en) 1999-10-25 2005-05-26 Altana Pharma Ag Phthalazinone derivatives as PDE 4 inhibitors
SK17052002A3 (sk) 2000-06-05 2003-12-02 Altana Pharma Ag Pyridazinónové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
US20040224316A1 (en) * 2000-08-10 2004-11-11 Tully Timothy P. Augmented cognitive training
US7868015B2 (en) * 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
HUP0303193A3 (en) * 2001-02-15 2007-08-28 Altana Pharma Ag Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them
MXPA03009583A (es) * 2001-04-25 2004-02-12 Altana Pharma Ag Ftalazinonas novedosas.
US7022696B2 (en) * 2001-04-25 2006-04-04 Altana Pharma Ag Piperazino-derivatives and their use as PDE4 inhibitor
EP2281818A1 (en) 2002-02-19 2011-02-09 Ono Pharmaceutical Co., Ltd. Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
WO2004017974A1 (en) 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-pyridazones and phthalazones as pde4 inhibitors
PL373146A1 (en) * 2002-08-10 2005-08-22 Altana Pharma Ag Pyridazinone-derivatives as pde4 inhibitors
WO2004018450A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-n-oxide-derivatives
AU2003255376A1 (en) * 2002-08-10 2004-03-11 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
WO2004098633A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Composition comprising a pde-4 inhibitor and a tnf alpha antagonist
US7365215B2 (en) 2003-07-14 2008-04-29 Ube Industries, Ltd. Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same
EP1716123A1 (en) * 2004-02-04 2006-11-02 Altana Pharma AG Pyridazinone derivatives and their use as pde4 inhibitors
JP4778449B2 (ja) * 2004-02-04 2011-09-21 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｐｄｅ４インヒビターとしての２−（ピペリジン−４−イル）−４，５−ジヒドロ−２ｈ−ピリダジン−３−オン誘導体
CN101163681A (zh) * 2005-04-21 2008-04-16 日本新药株式会社 2,3-二氮杂萘酮衍生物及其医药品
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8304436B2 (en) 2007-05-16 2012-11-06 Nycomed Gmbh Pyrazolone derivatives as PDE4 inhibitors
AR074318A1 (es) 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
BR112013031791A2 (pt) * 2011-06-17 2017-01-31 Takeda Gmbh derivados de ftalazinona-pirrolopirimidinacarboxamida
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
JP6545148B2 (ja) 2013-03-13 2019-07-17 フラットリー ディスカバリー ラブ，エルエルシー ピリダジノン化合物及び嚢胞性線維症の治療のための方法
US20150050626A1 (en) * 2013-03-15 2015-02-19 Dart Neuroscience, Llc Systems, Methods, and Software for Improving Cognitive and Motor Abilities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
CA2400368A1 (en) * 1992-12-02 1994-06-09 Allen J. Duplantier Catechol diethers as selective pde iv inhibitors
EP0634404A1 (en) * 1993-07-13 1995-01-18 Rhone Poulenc Agriculture Ltd. Phtalazin derivatives and their use as pesticides
AU705229B2 (en) * 1994-08-09 1999-05-20 Eisai R&D Management Co., Ltd. Fused pyridazine compound

Also Published As

Publication number Publication date
ATE233247T1 (de) 2003-03-15
EE9900274A (et) 2000-02-15
CA2276455A1 (en) 1998-07-23
SK283270B6 (sk) 2003-04-01
CN1249749A (zh) 2000-04-05
ES2193508T3 (es) 2003-11-01
CY2446B1 (en) 2004-11-12
CN1127487C (zh) 2003-11-12
NO993301D0 (no) 1999-07-02
AU5862998A (en) 1998-08-07
NO313137B1 (no) 2002-08-19
AU735934B2 (en) 2001-07-19
PL334561A1 (en) 2000-03-13
HK1024692A1 (en) 2000-10-20
NZ336573A (en) 2000-10-27
DE69811645T2 (de) 2003-12-04
WO1998031674A1 (en) 1998-07-23
EP0971901B1 (en) 2003-02-26
NO993301L (no) 1999-09-10
SK95199A3 (en) 1999-12-10
CA2276455C (en) 2006-10-31
DK0971901T3 (da) 2003-06-10
CZ253399A3 (cs) 2000-05-17
BR9806752A (pt) 2000-03-14
IL130659A (en) 2002-07-25
KR20000070150A (ko) 2000-11-25
EP0971901A1 (en) 2000-01-19
PL189418B1 (pl) 2005-08-31
CZ293815B6 (cs) 2004-08-18
HUP0001541A2 (hu) 2001-05-28
EA002764B1 (ru) 2002-08-29
JP2001508078A (ja) 2001-06-19
EE03968B1 (et) 2003-02-17
DE69811645D1 (de) 2003-04-03
TR199901653T2 (xx) 1999-10-21
IL130659A0 (en) 2000-06-01
PT971901E (pt) 2003-07-31
US6103718A (en) 2000-08-15
SI0971901T1 (en) 2003-10-31
HUP0001541A3 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
EA199900620A1 (ru) Фталазиноны
EA199800667A1 (ru) Новые фенантридины
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
EA199900758A1 (ru) Малые молекулы, полезные при лечении воспалительных заболеваний
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
TR199902400T2 (xx) Fungusit etkinlik g�steren terkiplerin birle�imleri.
EA199900936A1 (ru) Фунгицидные трифторметилалкиламинотриазолопиримидины
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
DK1193270T3 (da) Pyrrolobenzodiazepiner
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200501253A1 (ru) Производные пиразоло[1,5-a][1,3,5]триазина в качестве лигандов каннабиноидных рецепторов
EA200200208A1 (ru) Синергитическая композиция
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
EA200500856A1 (ru) Новые химические соединения
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
FI914723A0 (fi) 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma.
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
EA200301100A1 (ru) Новые фталазиноны
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6

Legal Events

Date Code Title Description
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU